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Abstract
Predicting outcomes that occur over time is important in clinical, population health, and health services
research. We compared changes in different measures of performance when a novel risk factor or marker
was added to an existing Cox proportional hazards regression model. We performed Monte Carlo
simulations for common measures of performance: concordance indices (c, including various
extensions to survival outcomes), Royston’s D index, R2-type measures, and Chambless’ adaptation of
the integrated discrimination improvement to survival outcomes. We found that the increase in
performance due to the inclusion of a risk factor tended to decrease as the performance of the
reference model increased. Moreover, the increase in performance increased as the hazard ratio or
the prevalence of a binary risk factor increased. Finally, for the concordance indices and R2-type
measures, the absolute increase in predictive accuracy due to the inclusion of a risk factor was greater
when the observed event rate was higher (low censoring). Amongst the different concordance indices,
Chambless and Diao’s c-statistic exhibited the greatest increase in predictive accuracy when a novel risk
factor was added to an existing model. Amongst the different R2-type measures, O’Quigley et al.’s
modification of Nagelkerke’s R2 index and Kent and O’Quigley’s 2w,a displayed the greatest sensitivity
to the addition of a novel risk factor or marker. These methods were then applied to a cohort of 8635
patients hospitalized with heart failure to examine the added benefit of a point-based scoring system for
predicting mortality after initial adjustment with patient age alone.
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1 Introduction
Predicting the occurrence of an adverse event or outcome over time is an important issue in clinical,
population health, and health services research. Time-to-event outcomes occur frequently in the
biomedical literature.1 The Cox proportional hazards regression model is the method most
frequently used to assess the eﬀect of patient characteristics on the risk of the occurrence of a
time-to-event outcome. Clinical prediction models allow clinicians to accurately assess patient
prognosis and permit eﬀective risk stratiﬁcation of patients.
There is a growing interest in identifying novel risk factors or markers (e.g. genetic factors,
biomarkers, lifestyle characteristics or patient characteristics) that add important prognostic
information above and beyond that contained in conventional clinical prediction models. The
importance of novel risk factors or markers is often quantiﬁed by the change in model
performance when a novel risk factor is added to an existing risk prediction model. Several
measures have been proposed to quantify the predictive performance of a Cox proportional
hazards regression model. These include extensions of concordance or c-statistics, R2-type
coeﬃcients, and Royston’s D index. Furthermore, extensions of the integrated
discrimination improvement (IDI) to survival models have been developed for quantifying the
incremental increase in prediction accuracy due to the inclusion of novel risk factors in an
existing model.2
In a recent paper, we examined the sensitivity of diﬀerent measures of model performance to the
inclusion of a novel risk factor or marker to an existing clinical prediction model when outcomes are
binary.3 Several articles have reported extensive comparisons of the performance and properties of
diﬀerent measures of model performance for predicting survival outcomes.2,4–9 While the statistical
properties of these performance measures have been extensively studied, there is a paucity of
research comparing the sensitivity of these diﬀerent performance measures for survival models to
the inclusion of novel risk factors or markers. The objective of the current paper was to
explore changes in popularly used measures of model performance for survival outcomes when a
novel risk factor or marker is added to an existing Cox proportional hazards regression model.
To address this objective, we performed an extensive set of simulations reﬂecting scenarios
that reﬂect current epidemiological research on new risk factors. Of note, our focus was solely on
the numerical impact of adding new predictors on the selected measures of model performance and
not on selecting the most appropriate measures of model performance or investigating their
limitations.
The paper is structured as follows: in Section 2 we describe diﬀerent measures of predictive
accuracy for use with survival models. In Section 3 we describe the design of an extensive set of
Monte Carlo simulations to examine the eﬀect of adding a novel risk factor to an existing reference
model on diﬀerent measures of model performance for Cox proportional hazards models. In Section
4 we report the results of these simulations. In Section 5, we present a case study illustrating the
application of these diﬀerent methods for assessing the added utility of a heart failure mortality
point-scoring system in predicting the hazard of death in patients hospitalized with heart failure.
Finally, in Section 6 we summarize our ﬁndings and place them in the context of the
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existing literature. In particular, we compare and contrast our ﬁndings on the eﬀect of adding novel
risk factors on diﬀerent measures performance for use with survival outcomes with previously
published work on the eﬀect of adding novel risk factors on diﬀerent performance measures for
use with binary outcomes.
2 Measures of predictive accuracy for time-to-event analyses
In this section we brieﬂy review diﬀerent measures of model performance that have been proposed
for use with time-to-event models: concordance (c) statistics, Royston’s D-index, R2-type measures,
and Chambless’ adaptation of the IDI for survival outcomes.
2.1 Notation and terminology
Let TS denote the outcome variable denoting time to the occurrence of the event of interest, and Z
denote a vector of p explanatory variables. Observed data for the ith subject consist of the following
triple: (Ti, di, Zi) (i ¼ 1, . . . , N), where T is a variable denoting the observed event time:
Ti ¼ minðTSi ,TCi Þ, where TC denotes the censoring time, which is independent of TS conditional
on Z, while di denotes an indicator variable denoting whether the event was observed to occur for the
ith subject (i.e. i ¼ IðTSi  TCi Þ). Where necessary, let  denote a speciﬁc event time.
The Cox proportional hazard regression model can be written as ðtjZÞ ¼ 0ðtÞ expf0ZÞ, where
0ðtÞ denotes the baseline hazard function and b is a p 1 vector of regression parameters that are
estimated from the ﬁtted model. This model can also be written in terms of the density function:
f ðtjZ;Þ ¼ h0ðtÞ exp

Z eZ R t0 h0ðuÞdu

[4], which will be used for deﬁning one of the R2-type
measures of predictive accuracy.
2.2 Concordance statistics for time-to-event outcomes
When outcomes are binary, the c-statistic is the probability that a randomly selected subject who
experienced the outcome has a higher predicted probability of experiencing the outcome than a
randomly selected subject who did not experience the outcome. It can be calculated by taking all
possible pairs of subjects consisting of one subject who experienced the outcome of interest and one
subject who did not experience the outcome. The c-statistic is the proportion of such pairs in which
the subject who experienced the outcome had a higher predicted probability of experiencing the
event than the subject who did not experience the outcome (i.e. out of all possible pairs in which one
subject experiences the outcome and one subject does not experience the outcome, it is the
proportion of pairs that are concordant).10,11 Diﬀerent adaptations of the c-statistic have been
proposed for use with time-to-event outcomes in which censoring may occur.8,9,12 Let Pi denote
the model-based predicted probability of the occurrence of an event prior to time  and let Di be an
event indicator at time  (i.e. Di¼ 1 if the ith subject experienced the event prior to time  and Di¼ 0
otherwise).
Chambless and Diao proposed a time-varying extension of the conventional c-statistic to survival
outcomes that most closely reﬂects the deﬁnition in the setting with binary outcomes.13 At a given
time , one considers all possible pairs of subjects consisting of one subject who experienced the
event prior to time , and one subject who had not experienced the event by time . Chambless and
Diao’s time-varying c-statistic is deﬁned to be the proportion of all such pairs in which the subject
who experienced the event prior to time  had a greater predicted probability of experiencing the
event prior to time  compared to the subject who had not experienced the event prior to time .
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We denote this approach by AUC(CD). Formally, AUCðCDÞðÞ ¼ PðPi4Pj jDiðÞ ¼ 1,Dj ðÞ ¼ 0Þ.
An estimator of this concordance index is AUCðCDÞðÞ ¼ E½ð1SðjPj ÞÞSðjPiÞIðPi5Pj ÞE½ð1SðjPiÞE½SðjPiÞ .
8
The most commonly used extension of the c-statistic to survival analysis was proposed by Harrell
et al.14 and was extensively studied by Pencina and D’Agostino.12 They formally deﬁned
AUCðHÞðÞ ¼ PrðPi4Pj jTSi 5TSj ,TSi 5 Þ, where TSi denotes the true survival time for the ith
subject (and thus, due to censoring, may not be observable for all subjects). The estimator is
based on concordant and discordant pairs. A pair of subjects is said to be concordant if the
subject with the longer survival time also had the greater predicted survival time (alternatively,
one can use the predicted probability of surviving until any ﬁxed time point). A pair of subjects
is said to be discordant if the subject with the longer survival time had the shorter predicted survival
time or the lower probability of surviving to some ﬁxed time point. A pair of subjects is said to be
usable if at least one of the subjects experienced the outcome (i.e. both subjects were not censored).
Harrell’s estimate of the c-statistic is deﬁned to be the proportion of all usable pairs that are
concordant. The formal estimator is AUCðHÞðÞ ¼
P
i 6¼j IðPi4Pj ÞIðTi5Tj,Ti5 ÞIðDi¼1Þf gP
i6¼j IðTi5Tj,Ti5 ÞIðDi¼1Þf g .
8
In Harrell’s deﬁnition of the c-index, pairs are excluded if the subject with the shorter follow-up
time was censored. Thus, the AUC(H) depends on the censoring mechanism, which is not a desirable
property. To address this limitation of AUC(H), Uno et al. proposed an alternative estimator of
Harrell’s concordance index that uses an inverse probability of censoring weights.8,9
AUCðUÞðÞ ¼
P
i,j
IðPi4Pj ÞIðTi5Tj,Ti5 ÞIðDi¼1ÞGðTiÞ2f gP
i,j
IðTi5Tj,Ti5 ÞIðDi¼1ÞGðTiÞ2f g , where G(Ti) is the Kaplan–Meier estimator
of the censoring time distribution.
Finally, Go¨nen and Heller proposed a concordance index (which we denote as GHCI) that is a
reversal of the above deﬁnitions of the c-statistic.15 The theoretical deﬁnition of their concordance
index is PrðTj4TijPi  Pj Þ, where Ti denotes the observed survival time for the ith subject. An
estimator of the GHCI is 2NðN1Þ
P
i5j
IðtrXi4 trXj Þ
1þexpðtrXjtrXiÞ þ
IðtrXi5trXj Þ
1þexpðtrXitrXj Þ
n o
(where the superscript tr
denotes the transpose of a vector), assuming that subjects are ordered according to increasing
linear predictors trXi. The GHCI assumes that the Cox model is correctly speciﬁed.
Strictly speaking, the GHCI is not a c-statistic. However, we include it in this sub-section since it
is a concordance-type index. We will use the term c-statistic when we are referring to one of
AUC(H), AUC(CD), or AUC(U). We will use the term concordance or concordance statistics
when we are referring to one of the three c-statistics or to the GHCI.
2.3 Royston’s D-index
Royston and Sauerbrei proposed a measure of prognostic separation in survival data that has been
referred to as D.16 D measures prognostic separation of survival curves and is closely related to the
standard deviation of the prognostic index. The prognostic index for each subject is deﬁned to be the
linear predictor from the ﬁtted Cox proportional hazards model. Ranking the prognostic index
across the sample, one assigns to the ith subject the ith expected standard normal order statistic
in a sample of the same size. Using a Cox proportional hazards model, one then regresses the
original time-to-event outcome on the expected standard normal order statistics. Royston’s
D-index is deﬁned to be the estimated regression coeﬃcient multiplied by
ﬃﬃﬃﬃﬃﬃﬃﬃ
8=
p
. D can be
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interpreted as an estimate of the log hazard ratio comparing two prognostic groups of equal size (i.e.
if one had dichotomized the linear predictor at the sample median).16
2.4 R2-type measures
A large number of diﬀerent R2-type measures for use with survival models have been proposed.16–30
Comprehensive reviews of these diﬀerent measures are provided by Choodari-Oskooei et al.,4,5
Hielscher et al.,6 and by Schemper and Stare.7 Most of these R2-type measures attempt to mimic
the deﬁnition of R2 for linear models: R2 ¼ Varð0ZÞ
Varð0ZÞþ2, where s
2 denotes the variance of the error
term in the linear model. Several authors have proposed lists of desirable properties for measures of
explained variation.5,6 Choodari-Oskooei et al. divided these measures into four diﬀerent classes:
measures of explained variation, measures of explained randomness, measures of predictive
accuracy, and a fourth class of miscellaneous measures that do not fall into any of the above
three classes.4,5 Measures in the ﬁrst class have an interpretation that most closely resembles the
popular interpretation of R2 for linear models.
Choodari-Oskooei et al. suggest that a measure of explained variation should satisfy four
properties: (i) independence from censoring (i.e. the measure is not aﬀected by the degree of
censoring in the data), (ii) monotonicity (i.e. that the measure of predictive accuracy takes on
higher values as the magnitude of the eﬀect of a covariate on the outcome increases),
(iii) interpretability, and (iv) robustness against inﬂuential observations.5 Based on these criteria,
Choodari-Oskooei et al. suggest that two measures of explained variation should be used: Kent and
O’Quigley’s R2PM ¼ Varð
0ZÞ
Varð0ZÞþ2=6 and Royston and Sauerbrei’s R
2
D ¼ D
2=ð8=Þ
D2=ð8=Þþ2=6 where D denotes
Royston’s D index described in Section 2.3. Amongst the measures of explained randomness,
they suggested that Kent and O’Quigley’s 2w be used, which can be approximated by
2w,a ¼ Varð
0ZÞ
Varð0ZÞþ1. We note that both Kent and O’Quigley measures assume that the ﬁtted model is
correct, since the estimated b coeﬃcients are used in the calculations of R2 and 2.
In another review, Hielscher et al. suggested that two diﬀerent measures of explained variation be
used: An R2 based on the Integrated Brier Score (IBS), R2IBS, proposed by Graf et al.
27 and R2SH of
Schemper and Henderson28 (Hielscher et al. use the notation R2D to refer to this latter measure,
however we are already using this term for Royston and Sauerbrei’s measure. As a further aside,
Hielscher et al. classiﬁed these two measures as measures of explained variation, whereas Choodari-
Oskooei described them as measures of predictive accuracy).
For binary prediction models, the Brier score is the mean squared prediction error. The IBS, an
extension of this concept to survival outcomes, is deﬁned as IBSðÞ ¼ R E½ðIðT4 Þ
SðjZÞÞ2dFZðZÞ, where IðT4 Þ 2 f0, 1g is the individual survival status at time  and SðjZÞ is
the predicted survival probabilities from the model with covariate vector Z. The R2 measure
based on the IBS is deﬁned as R2IBSðÞ ¼ 1 IBSðÞIBS0ðÞ, where IBS0ðÞ is the IBS for the marginal
estimate of survival probabilities obtained using the Kaplan–Meier estimates.27 Whereas the IBS
will decrease with improvements in model ﬁt, the R2IBS will increase with improvements in model ﬁt.
The latter quantity thus performs as one would expect for R2-type measures.
Schemper and Henderson’s integrated measure of predictive accuracy is deﬁned as
R2SH ¼ 2
R 
0 E½SðtjZÞf1 SðtjZÞg f ðtÞdtWðÞ, where (0,) is the follow-up period and
WðÞ ¼ R 0 f ðtÞdt
1
.
Two diﬀerent R2-type measures, which fall into Choodari-Oskooei et al.’s miscellaneous class, are
based on the likelihood ratio statistic for comparing the full model with the null model. Allison
suggested R2 ¼ 1 expðLR=NÞ,31 while Nagelkerke deﬁned a generalized R2 index as
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R2N ¼ 1expðLR=NÞ1expðL0=NÞ , where LR is the global log-likelihood ratio statistic for testing the importance of
all p predictors in the regression model, L0 is the –2 log likelihood for the null model, and N denotes
the sample size or number of subjects in the sample.10,23,32 In the latter measure, Allison’s suggested
measure is scaled by its maximum possible value, so that the resultant measure will lie between
0 and 1. O’Quigley et al. have criticized these measures as being inconsistent in the presence of
censoring, as they converge to zero as the percentage of censoring increases25 (p. 481). They
proposed a modiﬁcation to these measures, in which N, the number of subjects, is replaced by K,
the number of uncensored subjects (i.e. the number of observed events). We will examine the
performance of the modiﬁed Nagelkerke index as a comparator to the measures described earlier.
2.5 IDI
Pencina et al. suggested that the improvement in predicting the probability of the occurrence of a
binary outcome due to the addition of a novel risk factor to an existing risk-prediction model can be
summarized using the IDI.33 Given a new regression model that includes a novel risk factor and an
older regression model in which this risk factor is omitted, the IDI is estimated as
IDI ¼ ð ^pnew,events  ^pnew,noneventsÞ  ð ^pold,events  ^pold,noneventsÞ
where ^pnew,events is the mean of the new model-based predicted probabilities of an event for those
who develop events, while ^pnew,nonevents is the mean of the new model-based predicted probabilities
of an event for those who do not develop an event. ^pold,events and
^pold,nonevents are deﬁned
similarly for the old regression model. The IDI is diﬀerent from the measures described in
the previous sub-sections because it is not a measure of model performance. Rather, it is a
measure for quantifying the improvements in predictive accuracy due to the inclusion of a novel
risk factor.
Chambless et al. proposed a time-varying extension of the IDI to survival outcomes, based on the
observation that the original IDI is related to the change in the proportion of variance explained
between the model with and without the novel risk factor (R2ðtÞnewandR2ðtÞold, respectively).2
Chambless et al. deﬁned this time-varying extension as IDIðtÞ ¼ R2ðtÞnew  R2ðtÞold, with
R^2ðtÞ ¼ V^arðSðtjXÞÞ
S^ðtÞð1S^ðtÞÞ, where S^ðtÞ denotes the mean survival function at time t across all subjects in
the sample, while V^arðSðtjXÞÞ denotes the variance of the survival function at time t across all
subjects. S^ðtjZiÞ is the estimated survival function derived from the estimated proportional
hazards regression model, while SðtÞ ¼ EðSðtjZÞÞ can be estimated by averaging the estimated
survival functions across all subjects in the sample. We note that this deﬁnition of R2 diﬀers from
those discussed in the previous sub-section.
2.6 Software
We used R software (version 2.15.2, R Foundation for Statistical Computing, Vienna, Austria) to
simulate the random datasets. AUC(CD), AUC(U), and GHCI were estimated using the AUC.cd,
UnoC, and GHCI functions in the survAUC package. The IBS of Graf et al., R2IBS, was estimated
using the pec and ibs functions in the pec package. Schemper and Henderson’s R2SH was estimated
using R code provided by Lara Lusa (http://cemsiis.meduniwien.ac.at/en/kb/science-research/
software/statistical-software/surevsurev/ – site accessed 26 September 2013)34 We used SAS
macros provided by Chambless and colleagues to compute the IDI (www.aricnews.net – site
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accessed 4 October 2013).2 The other measures of model performance were estimated using
components extracted from the ﬁtted Cox proportional regression models.
3 Methods – Monte Carlo simulations
An extensive series of Monte Carlo simulations was performed, similar in design to those in a recent
study examining this issue in the context of binary outcomes and logistic regression models.3 Our
simulations incorporated the following design elements: (i) an existing prediction model that related
a continuous risk factor to the hazard of the occurrence of a time-to-event outcome with a given
predictive accuracy (i.e. the ‘reference model’), (ii) the addition of either a novel binary or
continuous risk factor to the existing model, (iii) variations in the magnitude of the correlation
between the existing continuous risk factor and the novel risk factor, (iv) variations in the prevalence
of the novel binary risk factor, (v) variation in the magnitude of the hazard ratio relating the novel
risk factor to the hazard of the occurrence of the outcome, (vi) scenarios with a high degree of
censoring (low observed event rate) versus scenarios with a low degree of censoring (high observed
event rate), (vii) censoring occurring due to administrative censoring versus censoring occurring due
to study dropout or loss to follow-up.
We describe one scenario in detail and then describe brieﬂy how this scenario was modiﬁed in
subsequent scenarios. For each of 1000 subjects, we randomly generated a continuous predictor
variable denoting an established risk factor from a standard normal distribution: x1i  Nð0, 1Þ.
We then simulated a novel binary risk factor from a Bernoulli distribution with parameter
Prisk-factor:x2i  BeðPriskfactorÞ. Thus, the prevalence of binary risk factor in the population is
Prisk-factor. In this ﬁrst scenario, the established, continuous, risk factor was assumed to be
independent of the novel binary risk factor (this will be modiﬁed in subsequent scenarios). A
time-to-event outcome was generated for each of the 1000 subjects using a Cox–Weibull model
for generating time-to-event outcomes.35 For each subject, the linear predictor was deﬁned as
LP ¼ 	1x1i þ 	2x2i. For each subject, we generated a random number from a standard uniform
distribution: uU(0,1). A survival or event time was generated for each subjects as follows: logðuÞ expðLPÞ
1=

. We set  and Z to be equal to 0.25 and 0.5, respectively. We set two diﬀerent
degrees of administrative censoring (25% and 90% right censoring when the study observation
period ended – thus the observed event rate was 75% and 10% in these two scenarios, respectively).
For the ﬁrst setting, we deﬁned t0 to be the 75th percentile of survival times in one simulated dataset
of size 1,000,000. Subjects whose survival times exceeded t0 were then subjected to administrative
censoring (t0 was deﬁned analogously in the setting with a high degree of administrative censoring).
Two Cox proportional hazards models were ﬁt in each simulated dataset: a regression model
consisting of only the continuous risk factor x1 and a regression model consisting of the continuous
risk factor x1 and the novel binary risk factor x2. The predictive accuracy of each of the two models
was determined using the diﬀerent methods described in the preceding section. The change in
predictive accuracy was then determined across 1000 simulated datasets (each consisting of 1000
subjects). For those measures of predictive accuracy that are time varying (AUC(CD), AUC(u), and
Chambless’ IDI), we estimated model performance at ¼ t0, where t0 is as deﬁned earlier. Similarly,
the IBS was determined over the maximum duration of follow-up.
In the Monte Carlo simulations, the following factors were varied: (1) the proportion of subjects
for whom an event was observed to occur: 0.10 versus 0.75 (low versus high rate of observed events);
(2) exp(a1) (the hazard ratio for the continuous risk factor): from 1 to 3 in increments of 0.2; (3) the
prevalence of the novel binary risk factor: 0.10, 0.25, and 0.50; (4) exp(a2) (the hazard ratio for the
novel binary risk factor): 1.10, 1.25, 1.50, and 2.0. We thus examined 264 (2 11 3 4) diﬀerent
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scenarios in which the novel risk factor was binary and was independent of the existing continuous
risk factor. Each statistical method was applied to the same simulated datasets, so that the simulated
datasets did not vary between the statistical methods.
We modiﬁed the above scenario by inducing a correlation between the existing continuous risk
factor and the novel binary risk factor. We examined two diﬀerent scenarios characterized by
diﬀerent degrees of correlation between the existing continuous risk factor and the novel binary
risk factor. To do so, we simulated two continuous risk factors from a standard bivariate normal
distribution with correlation r between the two components. The ﬁrst component was used as the
existing continuous risk factor. We categorized the second component at a given threshold, and
deﬁned the novel binary risk factor to be present if the second component lay above the threshold,
and to be absent if the second component lay below the threshold. The threshold was selected so that
the prevalence of the novel binary risk factor was as described earlier (0.1, 0.25, and 0.50). The
simulations then proceeded as described earlier. In the ﬁrst modiﬁcation, r was set to 0.5, while in
the second modiﬁcation, r was set to 0.8.
The above three sets of simulations examined changes in predictive accuracy due to the inclusion
of a novel binary risk factor to a Cox proportional hazards model that consisted of an existing
continuous risk factor. We modiﬁed the original scenario to examine changes in model performance
due to the inclusion of a novel continuous risk factor. In this fourth set of simulations, the novel risk
factor was simulated from a standard normal distribution. Furthermore, it was generated so as to be
independent of the continuous existing risk factor. The hazard ratio for the continuous novel risk
factor took on the following values: 1.1, 1.25, 1.5, and 2. We thus examined 88 diﬀerent scenarios
(two degrees of censoring 11 hazard ratios for the existing continuous risk factor four hazard
ratios for the novel continuous risk factor). The simulations then proceeded as described earlier.
The above sets of simulations used data-generating processes that induced administrative
censoring, with either 25 or 90% of subjects being censored due to study termination (all subjects
whose survival time exceeded t0 had their event time censored at time t0). We then repeated each of
the above scenarios in which the novel risk factor was independent of the existing continuous risk
factor (due to space and time constraints, we did not examine the scenarios in which the two risk
factors were correlated), with censoring induced by loss to follow-up or study dropout. We induced
study dropout so that some subjects dropped out prior to the true event time. We determined each
subject’s dropout status from a Bernoulli distribution with parameter Pdropout. Subjects who were
selected as dropping out had a dropout time selected from a uniform (0,TS) distribution, where TS
denotes the subject’s true event time. We examined two diﬀerent values of Pdropout: 0.25 and 0.90, so
that 25% and 90% of subjects were subject to censoring due to study dropout, with the event being
observed for the remaining subjects. The simulations then proceeded as described earlier.
4 Results – Monte Carlo simulations
We report our results separately for the four scenarios deﬁned by the nature of the novel risk factor
(binary versus continuous) and its correlation with the existing continuous risk factor. Results are
reported in detail for the ﬁrst setting and more brieﬂy for the remaining settings.
4.1 Binary risk factor independent of existing continuous risk factor
Results for the scenarios with an independent binary risk factor that is uncorrelated with the existing
continuous risk factor, in which there was a low event rate (i.e. high rate of censoring), and in which
censoring was due to administrative censoring are reported in Figures 1 to 3. In Figure 1, we report
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the changes for the four concordance statistics (AUC(H), AUC(CD), AUC(U), and GHCI) when
the novel binary risk factor was added to the regression model. Several observations merit comment.
First, improvements in concordance due to the inclusion of the binary risk factor decreased as the
concordance of the reference model increased. Second, improvements in concordance increased as
the hazard ratio of the novel binary risk factor increased. Third, improvements in concordance due
to the addition of the novel binary risk factor increased as the prevalence of the binary risk factor
increased. Fourth, improvements in AUC(H) were essentially identical to improvements in
AUC(U). Fifth, improvements in the AUC(CD) were modestly greater than improvements in the
other three concordance measures while improvements in GHCI were modestly lower than
improvements in the other three concordance measures. Changes in Royston’s D index due to the
inclusion of the novel binary risk factor displayed similar patterns (Figure 2).
The relationship between the change in each R2-type measure and the R2 of the univariate model
is described in Figure 3. Because Chambless characterized the IDI as a diﬀerence in R2-type
measures, we have superimposed on this ﬁgure the relationship between Chambless’ IDI and
Chambless’ estimate of R2 for the reference model. Three of the R2-type measures (the adapted
Nagelkerke R2N statistic, R
2
PM, and 
2
w,a) displayed similar patterns to those described earlier. A
fourth measure, R2D, displayed an attenuation in the improvement in R
2 due to the inclusion of
the novel risk factor when the R2 of the univariate model was very low. The pattern of results for
Chambless’ adaptation of IDI and for R2SH was less consistent than the results for the other R
2-type
measures and the results described in the preceding paragraph. Furthermore, for both of these
measures, improvements in model performance increased due the inclusion of the binary risk
factor as the performance of the univariate model increased. For any given scenario, the adapted
R2N displayed greater increases due to the addition of the binary risk factor than did the other R
2-
type measures. Both the IDI and the change in R2IBS displayed less variability across the diﬀerent
scenarios than did the other R2 measures. Finally, Chambless’ R2, R2SH, and R
2
IBS, displayed
decreased variability across the diﬀerent baseline models compared to that observed for the other
R2-measures.
The above ﬁndings pertain to the settings with a low observed event rate (i.e. the outcome was
observed to occur for approximately 10% of subjects, with the remainder being subject to
administrative censoring). Results for the settings with a high observed event rate (i.e. the
outcome was observed to occur for approximately 75% of subjects, with the remainder being
subject to administrative censoring) were similar to those observed in the setting with a low
observed event rate (Figures 4 to 6). However, the absolute increase in concordance due to the
inclusion of the novel binary risk factor tended to be greater when the observed event rate was high
compared to when it was low. Second, diﬀerences between AUC(CD) and the other three
concordance measures were ampliﬁed, while diﬀerences between GHCI and AUC(H) and
AUC(U) were attenuated. The increase in the observed event rate tended to magnify the absolute
increase in Royston’s D index, albeit to a lesser degree than for the concordance indices. The
diﬀerences between the previously observed results for R2SH and Chambless’ adaptation of the
IDI from those of the other R2-type measures (i.e. the previously observed increasing magnitude
of improvements as the R2 of the reference model increased) were no longer apparent in the settings
with a high observed event rate. Diﬀerences between R2N and 
2
w,a were substantially diminished in
the presence of a high event rate. Finally, Chambless’ R2, R2SH, and R
2
IBS of the univariate model
displayed increased variability in the presence of a high event rate compared to in the presence of a
low event rate. However, this measure still displayed decreased variability compared to the other R2-
type measures. Changes in Chambless’ R2, R2SH, and R
2
IBS due to the inclusion of a binary risk factor
tended to be smaller in magnitude compared to changes in the other R2-type measures.
1064 Statistical Methods in Medical Research 26(3)
5 1. 0 0 1. 0 5 0. 0 0 0. 0
c−
st
at
is
tic
 o
f u
ni
va
ria
te
 m
od
el
Change in c−statistic
Pr
ev
al
en
ce
: 0
.1
0
H
R
 =
 2
 (H
ar
re
ll)
H
R
 =
 1
.5
 (H
ar
re
ll)
H
R
 =
 1
.2
5 
(H
ar
re
ll)
H
R
 =
 1
.1
 (H
ar
re
ll)
H
R
 =
 2
 (C
D
)
H
R
 =
 1
.5
 (C
D
)
H
R
 =
 1
.2
5 
(C
D
)
H
R
 =
 1
.1
 (C
D
)
H
R
 =
 2
 (G
H
C
I)
H
R
 =
 1
.5
 (G
H
C
I)
H
R
 =
 1
.2
5 
(G
H
C
I)
H
R
 =
 1
.1
 (G
H
C
I)
H
R
 =
 2
 (U
no
)
H
R
 =
 1
.5
 (U
no
)
H
R
 =
 1
.2
5 
(U
no
)
H
R
 =
 1
.1
 (U
no
)
5 1. 0 0 1. 0 5 0. 0 0 0. 0
c−
st
at
is
tic
 o
f u
ni
va
ria
te
 m
od
el
Change in c−statistic
Pr
ev
al
en
ce
: 0
.2
5
0.
50
0.
55
0.
60
0.
65
0.
70
0.
75
0.
50
0.
55
0.
60
0.
65
0.
70
0.
75
0.
50
0.
55
0.
60
0.
65
0.
70
0.
75
5 1. 0 0 1. 0 5 0. 0 0 0. 0
c−
st
at
is
tic
 o
f u
ni
va
ria
te
 m
od
el
Change in c−statistic
Pr
ev
al
en
ce
: 0
.5
0
F
ig
u
re
4
.
R
e
la
ti
o
n
sh
ip
b
e
tw
e
e
n
ch
an
ge
in
c-
st
at
is
ti
c
an
d
c-
st
at
is
ti
c
o
f
u
n
iv
ar
ia
te
m
o
d
e
l
(h
ig
h
ev
e
n
t
ra
te
–
u
n
co
rr
el
at
e
d
b
in
ar
y)
.
Austin et al. 1065
4. 0 3. 0 2. 0 1. 0 0. 0
D
 in
de
x 
of
 u
ni
va
ria
te
 m
od
el
Change in D index
Pr
ev
al
en
ce
: 0
.1
0
H
R
 =
 2
H
R
 =
 1
.5
H
R
 =
 1
.2
5
H
R
 =
 1
.1
4. 0 3. 0 2. 0 1. 0 0. 0
D
 in
de
x 
of
 u
ni
va
ria
te
 m
od
el
Change in D index
Pr
ev
al
en
ce
: 0
.2
5
0.
0
0.
5
1.
0
1.
5
0.
0
0.
5
1.
0
1.
5
0.
0
0.
5
1.
0
1.
5
4. 0 3. 0 2. 0 1. 0 0. 0
D
 in
de
x 
of
 u
ni
va
ria
te
 m
od
el
Change in D index
Pr
ev
al
en
ce
: 0
.5
0
F
ig
u
re
5
.
R
e
la
ti
o
n
sh
ip
b
e
tw
e
e
n
ch
an
ge
in
D
in
d
e
x
an
d
D
in
d
e
x
o
f
u
n
iv
ar
ia
te
m
o
d
e
l
(h
ig
h
ev
e
n
t
ra
te
–
u
n
co
rr
e
la
te
d
b
in
ar
y)
.
1066 Statistical Methods in Medical Research 26(3)
R
2 
of
 u
ni
va
ria
te
 m
od
el
Change in R2/IDI
Pr
ev
al
en
ce
: 0
.1
0
H
R
 =
 2
 (C
ha
m
bl
es
s)
H
R
 =
 1
.5
 (C
ha
m
bl
es
s)
H
R
 =
 1
.2
5 
(C
ha
m
bl
es
s)
H
R
 =
 1
.1
 (C
ha
m
bl
es
s)
H
R
 =
 2
 (R
2.
N
ag
el
ke
rk
e)
H
R
 =
 1
.5
 (R
2.
N
ag
el
ke
rk
e)
H
R
 =
 1
.2
5 
(R
2.
N
ag
el
ke
rk
e)
H
R
 =
 1
.1
 (R
2.
N
ag
el
ke
rk
e)
H
R
 =
 2
 (R
2.
P
M
)
H
R
 =
 1
.5
 (R
2.
P
M
)
H
R
 =
 1
.2
5 
(R
2.
P
M
)
H
R
 =
 1
.1
 (R
2.
P
M
)
H
R
 =
 2
 (R
2.
D
)
H
R
 =
 1
.5
 (R
2.
D
)
H
R
 =
 1
.2
5 
(R
2.
D
)
H
R
 =
 1
.1
 (R
2.
D
)
H
R
 =
 2
 (r
ho
.w
.a
)
H
R
 =
 1
.5
 (r
ho
.w
.a
)
H
R
 =
 1
.2
5 
(r
ho
.w
.a
)
H
R
 =
 1
.1
 (r
ho
.w
.a
)
H
R
 =
 2
 (R
2.
IB
S
)
H
R
 =
 1
.5
 (R
2.
IB
S
)
H
R
 =
 1
.2
5 
(R
2.
IB
S
)
H
R
 =
 1
.1
 (R
2.
IB
S
)
H
R
 =
 2
 (R
2.
S
H
)
H
R
 =
 1
.5
 (R
2.
S
H
)
H
R
 =
 1
.2
5 
(R
2.
S
H
)
H
R
 =
 1
.1
 (R
2.
S
H
)
R
2 
of
 u
ni
va
ria
te
 m
od
el
Change in R2/IDI
Pr
ev
al
en
ce
: 0
.2
5
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.000.020.040.060.080.10
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.000.020.040.060.080.10
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.000.020.040.060.080.10
R
2 
of
 u
ni
va
ria
te
 m
od
el
Change in R2/IDI
Pr
ev
al
en
ce
: 0
.5
0
F
ig
u
re
6
.
R
e
la
ti
o
n
sh
ip
b
e
tw
e
e
n
ch
an
ge
in
R
2
an
d
R
2
o
f
u
n
iv
ar
ia
te
m
o
d
e
l
(h
ig
h
ev
e
n
t
ra
te
–
u
n
co
rr
e
la
te
d
b
in
ar
y)
.
Austin et al. 1067
When censoring was due to study dropout and event rates were high, results were qualitatively
similar to those described earlier in the settings with administrative censoring. One noticeable change
was that, in the presence of censoring due to study dropout, the eﬀect of a novel marker was more
pronounced on 2w,a than it was on the modiﬁed Nagelkerke R
2. The R2IBS of the reference model
displayed increased variability in the presence of censoring due to study dropout than in the presence
of administrative censoring when the event rate was low. Furthermore, changes in R2SH and R
2
IBS due
to the addition of the novel risk factor tended to decrease with increasing performance of the
reference model, whereas the reverse was observed in the presence of administrative censoring
when the event rate was low.
4.2 Binary risk factor correlated with the existing continuous risk factor
We considered four diﬀerent sets of scenarios in which the novel binary risk factor was correlated
with the existing continuous risk factor and in which subjects were subject to administrative
censoring (low observed event rate versus high observed event rate; correlation of 0.5 versus
correlation of 0.8). Results were qualitatively similar to those described above (results for the
scenarios with a high observed event rate and a correlation of 0.5 are described in Figures A to C
in the online supplemental material (available at http://smm.sagepub.com), the other results are not
provided). The primary exception was that the changes in concordance and Royston’s D index did
not decrease smoothly as the predictive accuracy of the reference model increased. Instead, there was
some jaggedness evident in the lines. In the presence of a low event rate, a low prevalence (10%) of
the binary risk factor, and a high correlation between the binary risk factor and the continuous risk
factor, then some of the R2 measures (in particular R2PM and 
2
w,a) displayed some changes in
behaviour, with the magnitude of increases in model performance due to the addition of the
binary risk factor increasing as the performance of the reference model increased.
4.3 Continuous risk factor independent of existing continuous risk factor
Results for the setting with a continuous novel risk factor that is uncorrelated with the existing
continuous risk factor, and in which there was a low observed event rate due to administrative
censoring, were similar to those noted in Section 4.1 (Figure 7). For the IDI, R2IBS and R
2
SH,
improvements in model performance due to the addition of the novel continuous risk factor
increased as the performance of the reference model increased. With a high observed event rate in
the presence of administrative censoring (Figure 8), all results were similar to those observed in
Section 4.1. As with the binary risk factor, the diﬀerences in the observed behaviour between R2SH,
R2IBS, and Chambless’ IDI and the other R
2-type measures disappeared in the presence of a high
event rate. For the concordance measures, the absolute increase in model accuracy was greater in the
presence of a high observed event rate compared to in the presence of a low observed event rate.
When censoring was due to study dropout, rather than to administrative censoring, results tended
to be qualitatively similar, with only minor deviations from those described in the previous
paragraph. When censoring was due to study dropout, absolute increases in the concordance
indices tended to be modestly greater compared to when censoring was due to administrative
censoring. When censoring was due to study dropout, the performance of AUC(H), AUC(Uno),
and the GHCI were similar to one another, while AUC(CD) tended to display greater changes in
discrimination due to the addition of the continuous novel risk factor than did the other
concordance measures. Furthermore, when censoring was due to study dropout, R2SH, R
2
IBS, and
Chambless’ IDI tended to have a behaviour that was more similar to that of the R2-type measures.
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5 Case study
We provide a brief case study to compare the change in diﬀerent measures of model performance
when a risk factor is added to an existing Cox proportional hazards regression model. The sample
consisted of patients hospitalized with heart failure and the survival outcome was time to death, with
patients censored after 365 days of follow-up.
The Enhanced Feedback for Eﬀective Cardiac Treatment (EFFECT) Study was a cluster
randomized trial intended to improve the quality of care for patients with cardiovascular disease
in Ontario, Canada.36,37 During the ﬁrst phase of the study, detailed clinical data on patients
hospitalized with heart failure between 1 April 1999 and 31 March 2001 at 103 hospitals in
Ontario, Canada were obtained by retrospective chart review. Data on patient demographics,
vital signs and physical examination at presentation, medical history, and results of laboratory
tests were collected. Subjects with missing data on continuous baseline covariates necessary
to estimate the risk score were excluded from the current case study, leaving 8635 patients
for analysis.
We considered two variables for predicting the hazard of death over the 365 days subsequent to
hospital admission. The ﬁrst predictor variable was patient age. The second was the EFFECT-HF
mortality prediction score, which is a point-based scoring system for predicting the risk of 30-day
and 1-year mortality.38 The score includes age, respiratory rate, systolic blood pressure, urea
nitrogen, sodium concentration, cerebrovascular disease, dementia, chronic obstructive
pulmonary disease, hepatic cirrhosis, cancer, and haemoglobin. Importantly, patient age is one of
the components of the EFFECT-HF mortality prediction score. The correlation between these two
variables was 0.63 in the study sample.
We considered two reference prediction models: the ﬁrst contained only patient age as a linear
variable, while the second contained only the EFFECT-HF score as a linear variable. To each
model, we then added the other variable. Thus, we examined the eﬀect of adding patient age to a
model that initially consisted of only the EFFECT-HF score, and we examined the eﬀect of adding
the EFFECT-HF score to a model that initially consisted of only patient age. For each of the
Cox proportional hazard regression models, we computed the performance measures described in
Section 2. We determined the change in each measure of model performance when the second
variable was added to the existing prediction model. All of the time-varying measures of model
performance were assessed at 365 days (the time at which all subjects were subject to administrative
censoring). Similarly, the IBS was determined over the 365 days of follow-up.
Within one year of hospital admission, 2825 (33%) patients died, while the remainder were
subject to administrative censoring after one year of follow-up. Adding age to a prediction model
that consisted of only the EFFECT-HF score resulted in negligible changes in predictive
performance (range from –0.0003 to 0.0046, Table 1). The relative change in model performance
due to the inclusion of age ranged from 0% to 1.6%. Thus, across all measures of model
performance, there was a consistent conclusion that adding age to a model consisting of the
EFFECT-HF score did not improve prognostic performance.
Adding the EFFECT score to a prediction model that consisted of only patient age resulted in
substantially larger changes in model performance (range from 0.0748 to 0.5237). Royston’s D
displayed the greatest absolute increase when the EFFECT-HF score was added to the model
consisting of age alone (0.5237). The changes in the four concordance indices due to the addition
of the EFFECT-HF score were similar to one another. The ordering of the absolute change in the
four concordance indices was similar to that observed in our simulations (Figure 7): the largest
absolute change was observed for AUC(CD), while the smallest absolute change was observed for
GHCI concordance index. There was greater disparity in the magnitude of the change in model R2
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across the diﬀerent R2-type measures. The relative change in the four concordance indices ranged
from 12.4 to 16.4%, while the relative change in Royston’s D was 80%. The relative change in the
diﬀerent R2-type measures ranged from 106% (2w,a) to 215% (R
2
IBS), while Chambless’ R
2-type
measure displayed a relative change of 191%. While all measures allowed one to conclude that
predictive accuracy increased with the inclusion of the EFFECT-HF score, the relative increase in
model performance varied substantially across the diﬀerent measures of model performance. In
particular, the relative increase in the concordance statistics was substantially less than that of the
R2-type measures.
These results are concordant with the results of our simulations. In our simulations, we found
that greater improvements in model performance were possible when the reference model had lower
predictive accuracy. In examining Table 1, one notes that, across all measures of model
performance, the reference model consisting of age had lower predictive accuracy than the
reference model consisting of the EFFECT-HF score. Thus, one would anticipate greater
improvements in model performance when adding the EFFECT-HF score to the reference model
consisting of age alone, compared to when adding age to the reference model that consisted of
the EFFECT-HF score. There is a simple explanation for these observations. The EFFECT-HF
score incorporates 11 variables, one of which is age. Thus, adding the EFFECT-HF score to a
model consisting of age is comparable to incorporating 10 additional covariates to the clinical
prediction model. However, adding age to the model consisting of the EFFECT-HF score has a
minimal eﬀect since the existing score already incorporates the eﬀect of age on the hazard of the
outcome.
6 Discussion
We used an extensive set of Monte Carlo simulations to explore changes in measures of model
performance for Cox proportional hazards models when a novel risk factor or marker was added to
an existing regression model. We summarize our ﬁndings in two separate sets of conclusions.
Table 1. Performance measures for predicting mortality in patients hospitalized with heart failure.
Performance
measure
Model:
age
only
Model:
ageþ
EFFECT
score
Absolute
change in
performance
Relative
change in
performance
(%)
Model:
EFFECT
score
only
Model:
EFFECT
scoreþ
age
Absolute
change in
performance
Relative
change in
performance
(%)
AUC(H) 0.6150 0.7002 0.0852 13.8 0.7004 0.7002 –0.0003 0.0
AUC(CD) 0.6220 0.7225 0.1004 16.1 0.7208 0.7225 0.0016 0.2
AUC(U) 0.6012 0.7001 0.0989 16.4 0.6998 0.7001 0.0003 0.0
GHCI 0.6012 0.6761 0.0748 12.4 0.6741 0.6761 0.0020 0.3
Royston’s D index 0.6566 1.1804 0.5237 79.8 1.1798 1.1804 0.0006 0.1
Chambless R2 0.0500 0.1456 0.0956 191.1 0.1448 0.1456 0.0008 0.5
R2PM 0.1074 0.2392 0.1317 122.6 0.2355 0.2392 0.0037 1.6
R2D 0.0933 0.2496 0.1563 167.4 0.2494 0.2496 0.0002 0.1
2w,a 0.1653 0.3408 0.1756 106.2 0.3362 0.3408 0.0046 1.4
R2 (Nagelkerke) 0.1470 0.3894 0.2424 164.8 0.3891 0.3894 0.0003 0.1
R2IBS 0.0398 0.1256 0.0857 215.2 0.1254 0.1256 0.0002 0.1
R2SH 0.0459 0.1382 0.0923 201.3 0.1379 0.1382 0.0003 0.2
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The ﬁrst set of conclusions pertains to factors that inﬂuence the sensitivity of a measure of model
performance to the inclusion of a novel risk factor or marker. The second set of conclusions pertains
to comparing the relative sensitivity of diﬀerent measures of model performance to the inclusion of a
novel risk factor or marker.
In examining factors that inﬂuence the sensitivity of a measure of model performance to the
inclusion of a novel risk factor, several observations merit mention. First, the increase in predictive
accuracy due to the inclusion of a novel risk factor tended to decrease as the predictive accuracy of
the reference Cox proportional hazards regression model increased. Second, the magnitude of the
increase in predictive accuracy due to the inclusion of a novel risk factor increased as the hazard
ratio associated with this novel risk factor increased. Third, the increase in predictive accuracy due
to the inclusion of a binary risk factor increased as the prevalence of the binary risk factor increased.
The above ﬁndings were observed to hold for all measures of predictive accuracy examined:
concordance indices, Royston’s D index, and R2-type measures. In some settings (low event rate
and administrative censoring), Chambless’ R2, R2IBS, and R
2
SH exhibited some discrepant patterns,
with improvements in model performance increasing as the performance of the reference model
increased. For the concordance indices, the absolute increase in predictive accuracy due to the
inclusion of a novel risk factor was greater when the observed event rate was higher compared to
when the observed event rate was lower.
In comparing the relative sensitivity of diﬀerent measures of model performance to the inclusion
of a novel risk factor, several observations merit mention. First, we observed that improvements in
AUC(H) were essentially identical to improvements in AUC(U). Thus, in settings reﬂective of those
that we considered in our simulations, these two estimators should result in similar conclusions
about the incremental beneﬁt of novel risk factors or markers. Second, the behaviour for Chambless’
adaptation of the IDI tended to be less consistent with those of the other measures of model
performance. In particular, in some scenarios, the behaviour of Chambless’ adaptation of IDI
was diﬀerent from that of the majority of R2-type measures and from the concordance indices
and from Royston’s D. In some instances, the magnitude of the IDI increased as the
performance of the reference model increased. This suggests that further attention needs to be
focussed on Chambless’ time-varying deﬁnition of R2. Given diﬀerences in performance between
this estimate and that of most of the other R2-type measures, further research is required to explore
its properties.
Some secondary observations include that the improvements in predictive accuracy and the
accuracy of the reference regression model were no longer strictly decreasing when the novel
binary risk factor was correlated with the existing continuous risk factor. Instead, the relations
were somewhat jagged. A similar phenomenon was observed in our prior study.3 In that prior
study, when a novel binary risk factor was added to an existing logistic regression model, and
when the novel risk factor was correlated with the existing continuous risk factor, then the
relation between the change in accuracy (using either the c-statistic or Nagelkerke’s R2 statistic)
and the accuracy of the reference logistic regression model displayed a similar jaggedness. The
similarity of this ﬁnding in both in settings with binary outcomes and in settings with time-to-
event outcomes suggests that this issue needs to be examined in greater detail in subsequent
research on the mathematical properties of these estimators. However, this is beyond the scope of
the current study. Finally, Chambless’ R2, R2IBS, and R
2
SH frequently displayed less variability across
the diﬀerent univariate or reference models compared to the other R2-type measures.
A limitation of the current study is that we have focussed exclusively on the setting in which a
single novel risk factor or marker is added to an existing reference clinical prediction model. This
was done to reﬂect what we perceive to be the most common scenario in research on novel risk
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factors and markers. Our methods could easily be extended to examine multiple novel risk factors or
markers. One would need to consider several factors in a multi-factorial design: (i) the correlation
between the diﬀerent novel risk factors or markers, (ii) the magnitude of the independent eﬀect of
each novel risk factor on the hazard of the outcome, and (iii) the prevalence of each of the novel risk
factors or markers. We see no reason to anticipate why the sensitivity of the diﬀerent performance
measures would diﬀer in the setting of multiple novel risk factors.
Many of the above observations have important consequences for researchers seeking to appraise
novel risk factors or markers (e.g. genetic factors, biomarkers, lifestyle characteristics, or patient
characteristics) that add prognostic information above and beyond that contained in conventional
clinical prediction models when outcomes are time-to-event in nature. First, identiﬁcation of risk
factors that have a stronger etiological eﬀect (i.e. that have a larger hazard ratio) will result in
greater improvements in predictive accuracy, provided that these hazard ratios relate to predictor
variables that have the same distribution. One way to achieve comparability in hazard ratios is by
standardizing the predictor so that it has unit variance, or letting the hazard ratio refer to the 75
versus 25 percentile.10,11 Second, identiﬁcation of binary risk factors that are common or have higher
prevalence in the population will result in greater improvements in predictive accuracy.39 Third,
greater improvements in absolute estimates of predictive accuracy can be expected in settings in
which existing risk prediction models have low predictive accuracy. For fair comparisons,
investigators should use the best existing model as the reference model to avoid overstating the
incremental beneﬁt of novel risk factors and markers.40 Similarly, reviewers and readers should
ascertain whether published studies have used the best available model as the reference model. Of
note, studies should be suﬃciently large for unbiased estimation of performance, since overﬁtting
will cause upward bias in larger models where relatively many factors are included in the
model.10,41,42 Finally, studies with longer durations of follow-up (and thus with a higher observed
event rate) will allow for greater increases in concordance due to the inclusion of a novel risk factor
than studies with shorter duration of follow-up (and thus with a lower observed event rate).
One of the key conclusions is that the ﬁndings of the current study are largely similar to those of a
previous study that compared changes in predictive accuracy when novel risk factors or markers are
added to logistic regression models for predicting binary outcomes.3 The similarities of the current
ﬁndings with those from the prior study suggest that these ﬁndings describe underlying properties of
the relations between the characteristics of diﬀerent risk factors and improvements in predictive
accuracy. It is important to note that consistent ﬁndings were observed regardless of the nature of
the outcome (survival versus binary) and regardless of the measure of predictive accuracy that was
used. Thus, the suggestions for biomedical researchers provided in the paragraph above are likely to
be relevant regardless of the nature of the outcome of interest or of how predictive accuracy is
quantiﬁed.
When selecting a measure of model performance, Harrell suggests that, while rank measures
(such as concordance indices) may be useful for describing a given prediction model, they may
not be very sensitive in choosing between competing models, and that this may be especially true
when the models are strong10 (page 78). Furthermore, he suggests that measures such as R2 are more
sensitive. However, he notes that an absolute change in R2 may be diﬃcult to interpret. Similarly,
Uno et al. suggested that while c-statistics are commonly used to quantify the predictive ability of
clinical prediction models, they are not sensitive for determining the incremental beneﬁt of
additional risk factors or markers9 (page 1113). Furthermore, Uno et al. suggested that using
diﬀerences in measures of explained variation may be more sensitive in detecting diﬀerences in
predictive ability. Our ﬁndings provide support for these comments: greater increase in predictive
accuracy is possible when the reference model has lower predictive accuracy. Concordance measures
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may, however, be slightly less sensitive to the inclusion of novel risk factors than are R2-type
measures. A related issue is the fact that the diﬀerent measures have diﬀerent ranges and
interpretations. The concordance indices and the R2-type measures are constrained to have values
that lie between 0 and 1, but in most reasonable applications, the concordance indices will
have values that lie between 0.5 and 1. Royston’s D index does not have this constraint.
The absolute increase in a given concordance index is, in most reasonable applications, bounded
by 0.5, while there is no such constraint for D. Thus, if the reference model has a high
degree of predictive accuracy, there is limited room for improvement with the addition of a new
risk factor.
We have examined a wide range of diﬀerent performance measures for assessing the performance
of a Cox proportional hazards regression model: concordance-type statistics, R2-type measures, and
Royston’s D. Several of these measures are analogues for survival outcomes of methods developed
for continuous or binary outcomes. For instance, concordance-type measures were based upon the
c-statistic for binary outcomes. The c-statistic is equivalent to using the area under the ROC curve
for logistic regression models. Its use is not without controversy. Lobo et al. have criticized its use on
several grounds, including that it ignores the goodness of ﬁt of the model and that it summarizes the
test performance over regions of the ROC space it which one would rarely operate.43 Similarly,
Hand criticizes the ROC curve area for ignoring diﬀerent misclassiﬁcation costs.44 Despite these
criticisms, we have considered the c-statistic for survival outcomes, as it is one of the most frequently
used performance measures in this context. Furthermore, the relationship between the concordance-
type measures and the ROC curve is diﬀerent in the context of survival analysis than is the case for
binary outcomes, where the two measures are identical.
We need to emphasize that performance measures such as concordance and explained variability
do not reﬂect correctness of the underlying model.45 Some may argue that the pragmatic behaviour
of a prediction model is most relevant, i.e. its ability to discriminate events from non-events
(c statistics) and provide (low and) high risk predictions for (non-)events. Furthermore, the
degree of increase in model performance metric is only one of the many criteria that should be
considered when deciding if the new variable should be added. Our examination of the relative
sensitivity of the diﬀerent performance measures should not be taken as a suggestion that the most
sensitive measure is necessarily the best measure. We suggest that our ﬁndings of relative sensitivity
be restricted to within-class comparisons. By doing so, one is restricting comparisons between
measures that have the same interpretation and that use the same scale. Despite Harrell’s caution
described earlier, changes in concordance-type statistics are frequently used to assess the value/
usefulness/clinical relevance of adding a novel risk factor to an existing clinical prediction model.
Our results indicate that AUC(CD) is slightly more sensitive to inclusion of novel risk factors that is
either AUC(H) or AUC(U), which both have nearly identical behaviour to one another, while
AUC(GHCI) is the least sensitive of the concordance-type indices. These results suggest that if
the focus is on detecting model improvement, then the use of AUC(CD) will have slight beneﬁts.
In reviews of diﬀerent R2-type measures, Choodari-Oskooei et al. recommended that, amongst the
diﬀerent measures of explained randomness, Kent and O’Quigley’s 2w,a be used. We note that
Hielscher et al. described this as a measure of predictive accuracy. In the current study, we found
that this measure was indeed one of the most sensitive of the R2-type measures. This observation,
together with Choodari-Oskooei et al.’s recommendation, provides further support for its more
widespread use.
In summary, of the diﬀerent concordance indices, Chambless and Diao’s concordance index
displays changes of a greater magnitude when a novel risk factor is added to an existing reference
model. Furthermore, it displayed consistent and stable behaviour across the range of simulated
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settings. Of the diﬀerent R2-type measures, O’Quigley et al.’s modiﬁed Nagelkerke R2 index and
Kent and O’Quigley’s 2w,a index displays the greatest increase in model performance when a novel
risk factor is added to an existing model.
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